Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

HBM; BMND1; EVR1; EVR4; LR3; LRP7; OPPG; OPS; OPTA1; VBCH2; Osteoporosis Pseudoglioma Syndrome; Exudative Vitreoretinopathy 1

  • Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5) Packages (Simulation)
  • Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5) Packages (Simulation)
  • Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5) Figure . Gene Sequencing (extract)
  • RPD102Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

USAGE of the Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPD102Hu01 Recombinant Low Density Lipoprotein Receptor Related Protein 5 (LRP5) Positive Control; Immunogen; SDS-PAGE; WB.
PAD102Hu01 Polyclonal Antibody to Low Density Lipoprotein Receptor Related Protein 5 (LRP5) WB; IHC; ICC; IP.
GUESTBOOK